Physician

Robert Stephen Dye, M.D.

According to 2025 Medicare claims, Robert Dye, M.D. (NPI: 1215095179) practices dermatology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is ROBERT STEPHEN DYE, M.D. APC (NPI: 1881728384; TIN: 331008225) and primary practice location at 91301-4231.

Dye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,512 traditional Medicare patients, billed 18,977 HCPCS/CPT codes, and received $1,231,255 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 561 prescription claims across 279 beneficiaries totaling $199,382 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 32 records totaling $791. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $745,615 to $1,231,255. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $24,990 to $199,382. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	831	11,166	$745,615
2016	824	11,390	$746,784
2017	755	10,081	$620,508
2018	757	10,111	$655,406
2019	686	9,478	$676,010
2020	673	8,852	$678,579
2021	714	8,455	$728,556
2022	1,434	15,755	$1,042,239
2023	1,523	17,007	$1,131,732
2024	1,512	18,977	$1,231,255

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	276	$24,990
2016	141	270	$32,456
2017	137	243	$13,983
2018	182	371	$74,580
2019	218	443	$169,990
2020	236	512	$153,756
2021	239	507	$158,668
2022	416	834	$217,104
2023	464	959	$217,893
2024	279	561	$199,382

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	713	1,077	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,065	1,817	$66
17000	Destruction of precancer skin growth, 1 growth	871	1,498	$34
88305	Pathology examination of tissue using a microscope, intermediate complexity	842	2,024	$27
17003	Destruction of precancer skin growth, 2-14 growths	748	7,201	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	13	364	$93,037
Fluorouracil	Fluorouracil	45	1,240	$1,888
Cephalexin	Cephalexin	131	1,743	$864
Valacyclovir	Valacyclovir Hcl	35	721	$820
Mometasone Furoate	Mometasone Furoate	45	1,162	$777

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$791	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Stephen Dye, M.D.?

Tedicare shows public-source Medicare data for Robert Stephen Dye, M.D. (NPI 1215095179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Stephen Dye, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Stephen Dye, M.D.?

Robert Stephen Dye, M.D. is linked to ROBERT STEPHEN DYE, M.D. APC (billing NPI 1881728384) in the available physician profile data.

Does Robert Stephen Dye, M.D. have Open Payments data?

Robert Stephen Dye, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.